 |
 |
|||||
 |
 |
 |
 |
 |
 |
|
References
PX’Therapeutics have been working with over 100 biopharmaceutical companies and academic research centres through service based contracts or research collaborations.
| List of non-confidential clients • Alfact Innovation (France) • BioInfoBank Institute (Pologne) • BioMérieux (France) • CEA (France) • CEREP (France) • CHU Grenoble (France) • CNRS (France) • Cyclacel (United Kingdom) • DBMS (Grenoble, France) • Delta Crystallon (The Netherlands) • ENS Lyon (France) • ExonHit Therapeutics (France /USA) • Fovea Pharmaceuticals (France) • Galderma (France) • Hopital Necker (France) • INSERM (France) • INSERM/UJF - Neurodegeneration and plasticity (France) • Institut Necker (France) • Invivogen (France) • Laboratoire français du fractionnement et des biotechnologies (LFB) (France) • LFB (France) • Merck IRBM (Italia) • Mérial (France) • Michigan University (USA) • Mymetics Corp. (USA) • OPI (France) • Pfizer (France) • Trophos (France) • University of New South Wales (Australia) • Viventia Biotech(Canada) |
List of partners & collaborators • CRSSA (Ministry of Defence, France) • European Synchrotron Research Facility (Grenoble, France) • GenHomme consortium (France) • GREPI, Research Group on Infl ammatory Process (Grenoble, France) • Institute of Stuctural Biology (Grenoble, France) • IGS, Structural & Genomic Data Group (Marseille, France) • Mérial (France) • OPI (France) |
PX’Therapeutics belongs to the global competitiveness bio-cluster “Lyon Biopole”
and is also a member of the Biotech Committee of the LEEM.
Zone Minatec Entreprises - 7 parvis Louis Néel - BP50 F 38040 Grenoble
Phone: +33(0)438 023 650 - Fax: +33(0)438 961 038
Phone: +33(0)438 023 650 - Fax: +33(0)438 961 038